$0.26 1%
CPHI Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About China Pharma Holding

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China.


China Pharma Holding
Price $0.26
Target Price Sign up
Volume 91,200
Market Cap $4.2M
Year Range $0.24 - $0.65
Dividend Yield 0%
Revenue per Employee $27,440
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '241.4M1.7M-290,000-960,000-820,000-0.073
Q4 '232.1M2.2M-79,000-1.2M-1.1M-0.116
Q3 '231.8M2M-230,000-780,000-660,000-0.294
Q2 '231.1M1.2M-150,000-590,000-400,000-0.299
Q1 '232M1.8M180,000-480,000-340,000-0.060

Insider Transactions View All

No recorded Insider transactions.

What is the Market Cap of China Pharma Holding?

The Market Cap of China Pharma Holding is $4.2M.

How Many People Work at China Pharma Holding?

As of our latest update, China Pharma Holding employed approximately 234 people worldwide. However, it's important to note that China Pharma Holding's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is China Pharma Holding's revenue per employee?

$27,440. To calculate China Pharma Holding's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of China Pharma Holding?

Currently, the price of one share of China Pharma Holding stock is $0.26.

How can I analyze the CPHI stock price chart for investment decisions?

The CPHI stock price chart above provides a comprehensive visual representation of China Pharma Holding's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling China Pharma Holding shares. Our platform offers an up-to-date CPHI stock price chart, along with technical data analysis and alternative data insights.

Does CPHI offer dividends to its shareholders?

As of our latest update, China Pharma Holding (CPHI) does not offer dividends to its shareholders. Investors interested in China Pharma Holding should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of China Pharma Holding?

Some of the similar stocks of China Pharma Holding are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.